Who funds COVID-19 research?
We count 248 funded COVID-19 projects, active between 2020 and 2035, from 8 funders. The most came from Wellcome (53 projects), EU · ERC (39 projects) and EU · Health (35 projects). The median award is $3M, across the 234 of 248 projects that list an amount.
- Funded projects
- 248
- Funders
- 8
- Median award
- $3M
- Open calls now
- 0
Top funders of COVID-19 research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| Wellcome | 53 | 21% | $2.1M |
| EU · ERC | 39 | 16% | $1.8M |
| EU · Health | 35 | 14% | $7.2M |
| EU · MSCA | 35 | 14% | $298K |
| NIH · NIAID | 15 | 6% | $7M |
| EU · Digital, Industry and Space | 7 | 3% | $3.1M |
| NIH · NIDA | 5 | 2% | $6M |
| EU · Food, Bioeconomy Natural Resources, Agriculture and Environment | 5 | 2% | $5.3M |
| EU · Culture, creativity and inclusive society | 5 | 2% | $3.2M |
| UKRI · EPSRC | 4 | 2% | $1.9M |
Projects whose title or summary mentions COVID-19. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open COVID-19 funding calls
No open call mentions COVID-19 in our listings today. We add new calls twice a day; create a free account to get an alert when one opens.
Funded COVID-19 projects
A sample, latest start first, at most three per program.
-
Innate Immune Regulation in Viral Infection and Cancer Chemotherapy
Wellcome · £3,294,461 · ends 2033
-
Viral genomic surveillance in the era of million-sequence trees
Wellcome · £2,084,119 · ends 2032
-
Fluorescent virus-like particles for investigating humoral responses to SARS- CoV-2 and other respiratory viruses.
Wellcome · £762,324 · ends 2031
-
Dartmouth Clinical and Translational Science Institute
NIH · NCATS · $4,073,191 · ends 2031
-
CTSA UM1 at the University of Alabama at Birmingham
NIH · NCATS · $9,869,052 · ends 2031
-
Microbiology of Treatment Shortening in Tuberculosis"
NIH · NIAID · $3,589,323 · ends 2031
-
Total Body Nuclear Imaging for the Development of Nanotheranostics
UKRI · EPSRC · £9,980,399 · ends 2031
-
Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens
NIH · NIAID · $6,977,446 · ends 2030
-
Mapping Health Equity: Equitable Intelligence For Emerging Infections (EI2)
UKRI · UKRI FLF · £1,608,389 · ends 2030
-
ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center
NIH · NHLBI · $17,693,191 · ends 2029
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “covid or sars-cov-2”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with COVID-19 calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free